A program to improve cancer care coordination and support
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
This study tests a new program that helps newly diagnosed or recurrent cancer patients get better support and communication with their healthcare teams before they start treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kentucky Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Lexington, Kentucky) |
| Trial ID | NCT06326567 on ClinicalTrials.gov |
What this trial studies
The C4 program is designed to enhance cancer care through a multi-level intervention that focuses on patient navigation, digital needs assessments, and a closed-loop referral system. It aims to improve communication and engagement between patients and healthcare teams while providing culturally appropriate educational resources. The program targets newly diagnosed or recurrent cancer patients who have not yet started treatment and addresses social determinants of health to ensure equitable care. By integrating supportive services and psychosocial care, the C4 program seeks to create a more patient-centered healthcare experience.
Who should consider this trial
Good fit: Ideal candidates are patients with newly diagnosed or recurrent cancer who have not yet initiated any treatment and have specific social determinants of health needs.
Not a fit: Patients who are unable to communicate in English or do not have internet access may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the coordination of cancer care and enhance patient engagement, leading to better health outcomes.
How similar studies have performed: Other studies have shown success with similar multi-level interventions aimed at improving cancer care coordination and addressing social determinants of health.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with newly diagnosed or recurrent cancer who have not initiated treatment of any kind, including surgery, medical management, and/or radiation * Patients with one reported social determinants of health (SDOH) need OR patients at high-risk for SDOH needs based on demographic information (racial \& ethnic minorities, medicaid/uninsured populations). * Willingness to provide informed consent to participate Exclusion Criteria: * Not able to understand and communicate in English * Unable and/or unwilling to access the internet on a phone, tablet, or computer
Where this trial is running
Lexington, Kentucky
- University of Kentucky — Lexington, Kentucky, United States (Recruiting)
Study contacts
- Principal investigator: Timothy Mullett, MD — University of Kentucky
- Study coordinator: Yvonne Taul, RN
- Email: yvonne.taul@uky.edu
- Phone: 859-323-2354
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.